Moderna on Twitter: "Accelerated research & development timeline of our novel coronavirus (SARS-CoV-2 or COVID-19) #vaccine candidate, mRNA-1273. Read more: https://t.co/5XdkPGIpUw #mRNA https://t.co/lJod450RXN" / Twitter
The tangled history of mRNA vaccines
Scientists Reverse Engineer mRNA Sequence of Moderna Vaccine | The Scientist Magazine®
Frontiers | Perspectives on RNA Vaccine Candidates for COVID-19
mRNA vaccines for infectious diseases: principles, delivery and clinical translation | Nature Reviews Drug Discovery
Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines | ACS Central Science
Moderna (MRNA), Pfizer (PFE) Covid-19 Vaccines Look Strong. How They Compare - Bloomberg
RNA Vaccines (mRNA Vaccine) - Basis of Pfizer and Moderna COVID-19 vaccines, Animation - YouTube
mRNA vaccines for COVID-19: what, why and how
Moderna (MRNA) Vaccine Is Found Highly Effective at Preventing Covid-19 - Bloomberg
The promise of mRNA vaccines: a biotech and industrial perspective | npj Vaccines
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability - ScienceDirect
Vaccines | Free Full-Text | Development of mRNA Vaccines: Scientific and Regulatory Issues
Vaccines | Free Full-Text | Neo-Antigen mRNA Vaccines
mRNA Vaccines - Layman's version (Pfizer/Moderna COVID-19 vaccines), plus some FAQs, Animation. - YouTube
How Moderna made its mRNA Covid vaccine so quickly: Noubar Afeyan
What are the advantages of an mRNA vaccine for COVID-19?
CIMB | Free Full-Text | Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line
COVID-19: safety and efficacy of the mRNA-1273 SARSCoV-2 vaccine (Moderna) against SARS-CoV-2
Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines | ACS Central Science
Read Public Citizen's Letter on the Moderna Vaccine Patent Dispute - The New York Times
Szegedi Tudományegyetem | Katalin Karikó, an Alumna of the University of Szeged, is the Founder of the Most Promising Vaccine Development against the Coronavirus
RACGP - Four things about mRNA vaccines researchers still want to find out
The promise of mRNA vaccines: a biotech and industrial perspective | npj Vaccines
mrna-20201231
